氧化应激与铁死亡在糖尿病型阳痿中的相关性研究进展

doi:10.3969/j.issn.1006-5725.2024.16.006

Abstract

Abstract:

Diabetes mellitus erectile dysfunction （DMED） is a common diabetic-related vascular， endocrine and neuropathy in clinical practice， and patients with DMED often present with symptoms such as difficulty in erection， prolonged erection time， poor hardness， and short sexual intercourse. The etiological mechanism is complex， and it is often closely related to many factors such as oxidative stress （OS）， inflammatory response， and neurological and endocrine lesions， which often cross-react and promote the progression of DMED lesions. In recent years， relevant studies have shown that OS and ferroptosis play a key role in DMED： OS can cause neurological and Abnormal endocrine function， decreased synthesis or bioavailability of penile vascular endothelium， spongy endothelial cell dysfunction and decreased smooth muscle diastolic function， resulting in penile erectile dysfunction， and ferroptosis has also been confirmed to be closely related to DMED， controlling OS and ferroptosis to improve erectile function in diabetic patients is a reasonable and effective treatment pathway， but the mechanism of action of ferroptosis leading to DMED needs to be further studied. Therefore， this article reviews the latest information on the correlation between OS and ferroptosis and DMED， aiming to provide a useful reference for exploring the mechanism of DMED， clinical prevention and treatment of DMED， and providing potential directions for future research in this field.

Key words: oxidative stress, ferroptosis, diabetic impotence, mechanism of action, research progress

CLC Number:

R698+.1

Ganggang LU,Shenglong LI,Yongqiang ZHAO,Yunpeng JIA,Yonglin LIANG,Yuanbo. ZHAO. Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence[J]. The Journal of Practical Medicine, 2024, 40(16): 2229-2235.

Figures/Tables 1

References 50

1	LI B， HU P， LIU K， et al. MiRNA‐100 ameliorates diabetes mellitus‐induced erectile dysfunction by modulating autophagy， anti‐inflammatory， and antifibrotic effects［J］. Andrology， 2024.doi： 10.1111/andr.13586 . doi: 10.1111/andr.13586
2	SUN H， SAEEDI P， KARURANGA S， et al. IDF Diabetes Atlas： Global， regional and country-level diabetes prevalence estimates for 2021 and projections for 2045［J］. Diabetes Res Clin Pract， 2022， 183： 109119. doi:10.1016/j.diabres.2023.110945 doi: 10.1016/j.diabres.2023.110945
3	LIU D F， JIANG H， HONG K， et al. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors［J］. Chin Med J （Engl）， 2010， 123（22）： 3258-3261.
4	LI K， ZHU A， GUTMAN J， et al. Cysteine-Rich Whey Protein Isolate （CR-WPI） Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway［J］. Oxid Med Cell Longev， 2022， 2022： 8151917. doi:10.1155/2022/8151917 doi: 10.1155/2022/8151917
5	LI S， ZHENG L， ZHANG J， et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy［J］. Free Radic Biol Med， 2021， 162： 435-449. doi:10.1016/j.freeradbiomed.2020.10.323 doi: 10.1016/j.freeradbiomed.2020.10.323
6	LI W， LI W， LENG Y， et al. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress［J］. DNA Cell Biol， 2020， 39（2）： 210-225. doi:10.1089/dna.2019.5097 doi: 10.1089/dna.2019.5097
7	ZHU Z， DUAN P， SONG H， et al. Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis［J］. Bioengineered， 2021， 12（2）： 12555-12567. doi:10.1080/21655979.2021.2010369 doi: 10.1080/21655979.2021.2010369
8	HAO L， MI J， SONG L， et al. SLC40A1 Mediates Ferroptosis and Cognitive Dysfunction in Type 1 Diabetes［J］. Neuroscience， 2021， 463： 216-226. doi:10.1016/j.neuroscience.2021.03.009 doi: 10.1016/j.neuroscience.2021.03.009
9	WANG X， MA H， SUN J， et al. Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic Osteoporosis［J］. Biol Trace Elem Res， 2022， 200（1）： 298-307. doi:10.1007/s12011-021-02627-z doi: 10.1007/s12011-021-02627-z
10	SHAMLOUL R， GHANEM H. Erectile dysfunction［J］. Lancet， 2013， 381（9861）： 153-165. doi:10.1016/s0140-6736(12)60520-0 doi: 10.1016/s0140-6736(12)60520-0
11	LI H， CHEN L P， WANG T， et al. Calpain inhibition improves erectile function in diabetic mice via upregulating endothelial nitric oxide synthase expression and reducing apoptosis［J］. Asian J Androl， 2018， 20（4）： 342-348. doi:10.4103/aja.aja_63_17 doi: 10.4103/aja.aja_63_17
12	ROYCHOUDHURY S， CHAKRABORTY S， CHOUDHURY A P， et al. Environmental Factors-Induced Oxidative Stress： Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction［J］. Antioxidants （Basel）， 2021， 10（6）： 837. doi:10.3390/antiox10060837 doi: 10.3390/antiox10060837
13	ZIRKIN B R， CHEN H. Regulation of Leydig cell steroidogenic function during aging［J］. Biol Reprod， 2000， 63（4）： 977-981. doi:10.1095/biolreprod63.4.977 doi: 10.1095/biolreprod63.4.977
14	JEREMY J Y， JONES R A， KOUPPARIS A J， et al. Reactive oxygen species and erectile dysfunction： possible role of NADPH oxidase［J］. Int J Impot Res， 2007， 19（3）： 265-280. doi:10.1038/sj.ijir.3901523 doi: 10.1038/sj.ijir.3901523
15	ZHANG L， HE Y， JIANG Y， et al. PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation［J］. Cell Death Dis， 2023， 14（4）： 233. doi:10.1038/s41419-023-05752-w doi: 10.1038/s41419-023-05752-w
16	GAJECKI D， GAWRYS J， WISNIEWSKI J， et al. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus［J］. Nutrients， 2021， 13（7）： 2306. doi:10.3390/nu13072306 doi: 10.3390/nu13072306
17	HU L L， ZHANG K Q， TIAN T， et al. Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1/ DDAH/PPAR-γ/eNOS pathways in streptozotocin-induced diabetic rats［J］. Biochem Biophys Res Commun， 2018， 507（1/4）： 9-14. doi:10.1016/j.bbrc.2018.10.036 doi: 10.1016/j.bbrc.2018.10.036
18	CHEN D， ZHANG K Q， LI B， et al. Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway［J］. Asian J Androl， 2017， 19（3）： 291-297. doi:10.4103/1008-682x.178486 doi: 10.4103/1008-682x.178486
19	SUN T， XU W， WANG J， et al. Saxagliptin alleviates erectile dysfunction through increasing stromal cell‐derived factor‐1 in diabetes mellitus［J］. Andrology， 2023， 11（2）： 295-306. doi:10.1111/andr.13296 doi: 10.1111/andr.13296
20	GALHOM R A， KORAYEM H E， IBRAHIM M A， et al. Urine-Derived Stem Cells Versus Their Lysate in Ameliorating Erectile Dysfunction in a Rat Model of Type 2 Diabetes［J］. Front Physiol， 2022， 13： 854949. doi:10.3389/fphys.2022.854949 doi: 10.3389/fphys.2022.854949
21	VOLPE C M O， VILLAR-DELFINO P H， DOS ANJOS P M F， et al. Cellular death， reactive oxygen species （ROS） and diabetic complications［J］. Cell Death Dis， 2018， 9（2）： 119. doi:10.1038/s41419-017-0135-z doi: 10.1038/s41419-017-0135-z
22	DURAN A M， BEESON W L， FIREK A， et al. Dietary Omega-3 Polyunsaturated Fatty-Acid Supplementation Upregulates Protective Cellular Pathways in Patients with Type 2 Diabetes Exhibiting Improvement in Painful Diabetic Neuropathy［J］. Nutrients， 2022， 14（4）： 761. doi:10.3390/nu14040761 doi: 10.3390/nu14040761
23	EISA N H， HELMY S A， EL-KASHEF D H， et al. Pramipexole protects against diabetic neuropathy： Effect on oxidative stress， TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators［J］. Int Immunopharmacol， 2024， 128： 111514. doi:10.1016/j.intimp.2024.111514 doi: 10.1016/j.intimp.2024.111514
24	ZHANG L， BAO B， GUO J， et al. Current status and prospects of diabetes mellitus induced erectile dysfunction： A bibliometric and visualization study［J］. Front Endocrinol （Lausanne）， 2023， 14： 1168744. doi:10.3389/fendo.2023.1168744 doi: 10.3389/fendo.2023.1168744
25	PAUL A， KUMAR M， DAS P， et al. Drug repurposing⁃A search for novel therapy for the treatment of diabetic neuropathy［J］. Biomed Pharmacother， 2022， 156： 113846. doi:10.1016/j.biopha.2022.113846 doi: 10.1016/j.biopha.2022.113846
26	ESCOBAR-MORREALE H F， MARTINEZ-GARCIA M A， MONTES-NIETO R， et al. Effects of glucose ingestion on circulating inflammatory mediators： Influence of sex and weight excess［J］. Clin Nutr， 2017， 36（2）： 522-529. doi:10.1016/j.clnu.2016.01.015 doi: 10.1016/j.clnu.2016.01.015
27	WANG Y， LI J， HUANG Y， et al. Tripartite motif⁃containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR‐1 and -2 and VEGFR2 in endothelial cells［J］. FASEB J， 2017， 31（5）： 2026-2036. doi:10.1096/fj.201600988rr doi: 10.1096/fj.201600988rr
28	NEMKOV T， SUN K， REISZ J A， et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage［J］. Haematologica， 2018， 103（2）： 361-372. doi:10.3324/haematol.2017.178608 doi: 10.3324/haematol.2017.178608
29	ROJAS D R， TEGEDER I， KUNER R， et al. Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species［J］. J Mol Med （Berl）， 2018， 96（12）： 1395-1405. doi:10.1007/s00109-018-1707-9 doi: 10.1007/s00109-018-1707-9
30	MORELLO E， SUTTI S， FOGLIA B， et al. Hypoxia‐inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine‐rich glycoprotein［J］. Hepatology， 2018， 67（6）： 2196-2214. doi:10.1002/hep.29754 doi: 10.1002/hep.29754
31	CAROTA I A， KENIG-KOZLOVSKY Y， ONAY T， et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury［J］. J Exp Med， 2019， 216（4）： 936-949. doi:10.1084/jem.20180009 doi: 10.1084/jem.20180009
32	DUCSAY C A， GOYAL R， PEARCE W J， et al. Gestational Hypoxia and Developmental Plasticity［J］. Physiol Rev， 2018， 98（3）： 1241-1334. doi:10.1152/physrev.00043.2017 doi: 10.1152/physrev.00043.2017
33	JAIN T， NIKOLOPOULOU E A， XU Q， et al. Hypoxia inducible factor as a therapeutic target for atherosclerosis［J］. Pharmacol Ther， 2018， 183： 22-33. doi:10.1016/j.pharmthera.2017.09.003 doi: 10.1016/j.pharmthera.2017.09.003
34	PHE V， ROUPRET M. Erectile dysfunction and diabetes： a review of the current evidence-based medicine and a synthesis of the main available therapies［J］. Diabetes Metab， 2012， 38（1）： 1-13. doi:10.1016/j.diabet.2011.09.003 doi: 10.1016/j.diabet.2011.09.003
35	刘洋，孙岳，杨安宁，等. 铁死亡参与高脂饮食诱导的ApoE-/-小鼠动脉粥样硬化及ox-LDL诱导的泡沫细胞形成过程［J］. 实用医学杂志， 2021， 37（5）： 585-590. doi:10.3969/j.issn.1006-5725.2021.05.006 doi: 10.3969/j.issn.1006-5725.2021.05.006
36	LI W， LI W， WANG Y， et al. Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury［J］. Cell Death Discov， 2021， 7（1）： 267. doi:10.1038/s41420-021-00656-0 doi: 10.1038/s41420-021-00656-0
37	YAN H F， ZOU T， TUO Q Z， et al. Ferroptosis： mechanisms and links with diseases［J］. Signal Transduct Target Ther， 2021， 6（1）： 49. doi:10.1038/s41392-020-00428-9 doi: 10.1038/s41392-020-00428-9
38	ZHANG S， BEI Y， HUANG Y， et al. Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice［J］. Mol Med， 2022， 28（1）： 121. doi:10.1186/s10020-022-00549-7 doi: 10.1186/s10020-022-00549-7
39	HUANG Z， MA Y， SUN Z， et al. Ferroptosis： potential targets and emerging roles in pancreatic diseases［J］. Arch Toxicol， 2024， 98（1）： 75-94. doi:10.1007/s00204-023-03625-x doi: 10.1007/s00204-023-03625-x
40	STOCKWELL B R， FRIEDMANN ANGELI J P， BAYIR H， et al. Ferroptosis： A Regulated Cell Death Nexus Linking Metabolism， Redox Biology， and Disease［J］. Cell， 2017， 171（2）： 273-285. doi:10.1016/j.cell.2017.09.021 doi: 10.1016/j.cell.2017.09.021
41	LUO E F， LI H X， QIN Y H， et al. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction［J］. World J Diabetes， 2021， 12（2）： 124-137. doi:10.4239/wjd.v12.i2.124 doi: 10.4239/wjd.v12.i2.124
42	FANG X， ARDEHALI H， MIN J， et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease［J］. Nat Rev Cardiol， 2023， 20（1）： 7-23. doi:10.1038/s41569-022-00735-4 doi: 10.1038/s41569-022-00735-4
43	CHEN P， CHEN Z， ZHAI J， et al. Overexpression of PRDX2 in Adipose-Derived Mesenchymal Stem Cells Enhances the Therapeutic Effect in a Neurogenic Erectile Dysfunction Rat Model by Inhibiting Ferroptosis［J］. Oxid Med Cell Longev， 2023， 2023： 4952857. doi:10.1155/2023/4952857 doi: 10.1155/2023/4952857
44	FENG H， LIU Q， DENG Z， et al. Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis［J］. Stem Cell Res Ther， 2022， 13（1）： 450. doi:10.1186/s13287-022-03147-w doi: 10.1186/s13287-022-03147-w
45	WANG Y， ZHANG X， CHEN Y， et al. Identification of hub biomarkers and exploring the roles of immunity， M6A， ferroptosis， or cuproptosis in rats with diabetic erectile dysfunction［J］. Andrology， 2023， 11（2）： 316-331. doi:10.1111/andr.13265 doi: 10.1111/andr.13265
46	XU W， SUN T， WANG J， et al. GPX4 Alleviates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting Ferroptosis［J］. Antioxidants （Basel）， 2022， 11（10）： 1896. doi:10.3390/antiox11101896 doi: 10.3390/antiox11101896
47	DU S， SHI H， XIONG L， et al. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy［J］. Front Endocrinol （Lausanne）， 2022， 13： 1011669. doi:10.3389/fendo.2022.1011669 doi: 10.3389/fendo.2022.1011669
48	王赛，高静. 富马酸二甲酯对过氧化氢诱导心脏微血管内皮细胞铁死亡的影响［J］. 实用医学杂志， 2023， 39（12）： 1494-1499. doi:10.3969/j.issn.1006-5725.2023.12.006 doi: 10.3969/j.issn.1006-5725.2023.12.006
49	FENG X， WANG S， SUN Z， et al. Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice［J］. Front Endocrinol （Lausanne）， 2021， 12： 626390. doi:10.3389/fendo.2021.626390 doi: 10.3389/fendo.2021.626390
50	WU Y， ZHAO Y， YANG H Z， et al. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose［J］. Biosci Rep， 2021， 41（2）： BSR20202924. doi:10.1042/bsr20202924 doi: 10.1042/bsr20202924

[1]	Kanglin CAI,Jinkai ZHANG,Liangdi RAN,Dajun HU,Zhitao FENG,Huilian. HUANG. Research progress on antidepressant pharmacological effects and mechanisms of Bupleuri Radix⁃Paeoniae Radix Alba herb⁃pair [J]. The Journal of Practical Medicine, 2024, 40(4): 447-452.
[2]	Shan GAO,Kun JI,Li ZHAO,Yujia XING,Yandong XIE,Xiqiang CAI. Research progress on esophageal squamous intraepithelial neoplasia [J]. The Journal of Practical Medicine, 2024, 40(3): 432-438.
[3]	Tianyue YU,Qian GUO,Hao HU,Yujing SU,Jianhua CHEN. Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia [J]. The Journal of Practical Medicine, 2024, 40(20): 2935-2940.
[4]	Jieqiong LIU,Yali YAO,Qian SUI,Ke LI,Fang HUANG,Yongqing. CAO. Based on the novel anti-heart failure drug ARNI， the mechanism of prevention of cardiotoxicity caused by anthracycline antitumor drugs was discussed [J]. The Journal of Practical Medicine, 2024, 40(2): 188-194.
[5]	Yunlong SUN,Zhe MENG,Xijia WANG,Lu. GAO. Liraglutide ameliorates high glucose⁃induced endothelial cell injuryvia Nrf2 [J]. The Journal of Practical Medicine, 2024, 40(15): 2051-2055.
[6]	Xin DOU,Changhui HE,Xiao MEI,Haidi PAN,Yuanxin MA,Wei. WANG. Research progress on the intervention of traditional Chinese medicine in IBS⁃D based on the "SCFAs⁃intestinal barrier" pathway [J]. The Journal of Practical Medicine, 2024, 40(15): 2177-2182.
[7]	Shan′gao HUANG,Yueling WU,Ying. ZHANG. Aiming for the future： The latest advances in targeted therapy for ovarian cancer [J]. The Journal of Practical Medicine, 2024, 40(14): 1901-1907.
[8]	Chun LONG,Hongying BI,Changzhen YANG,Jiakai WANG,Yan TANG,Xu. LIU. Emodin upregulates the Sirt2 to attenuate LPS-induced oxidative stress response in RAW264.7 cells [J]. The Journal of Practical Medicine, 2024, 40(13): 1785-1790.
[9]	Ruyue XUE,Yuexian LI,Defeng. SUN. Research progress on stellate ganglion block improving postoperative cognitive dysfunction [J]. The Journal of Practical Medicine, 2024, 40(11): 1500-1504.
[10]	Haixia YUAN,Xinmin HAN,Tianyi CHEN,Yuchen. SONG. Progress on structural abnormalities in the cerebral cortex in children with attention deficit/hyperactivity disorder [J]. The Journal of Practical Medicine, 2024, 40(10): 1455-1459.
[11]	LU Tian⁃ long, YANG Qiying, YANG Shiwen, SONG Xiaolong.. Molecular mechanism of CARM1 regulating ferroptosis in malignant biology of lung cancer cells [J]. The Journal of Practical Medicine, 2023, 39(9): 1098-1104.
[12]	CHEN Lu, LIU Yuan.. Alpinetin targets Nrf2 to inhibit oxidative stress in H9C2 cells [J]. The Journal of Practical Medicine, 2023, 39(7): 813-818.
[13]	XU Hong, SUN Wei, LIAO Zonghua, LI Mingmin.. Curative effect of high flow humidified oxygen delivery device combined with glutathione on AECOPD patients [J]. The Journal of Practical Medicine, 2023, 39(5): 607-612.
[14]	LIU Xueqing, GONG Xiuqun, WANG Xia, WANG Qiwei, LU Jun.. Therapeutic mechanism of edaravone dexboeol on vascular dementia [J]. The Journal of Practical Medicine, 2023, 39(4): 505-509.
[15]	Yadan CHE,Lixia. LI. Reaserch progress on small molecule anti⁃angiogenic drugs for advanced breast cancer [J]. The Journal of Practical Medicine, 2023, 39(22): 2866-2871.

Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 50

Related Articles 15

Recommended Articles

Metrics

Comments